Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Limited has launched OsteoRx, a special purpose vehicle aimed at advancing cellular regenerative medicine, with an initial investment of AUD 0.5 million. This strategic move involves a partnership with renowned scientists and a controlling stake in RxCell Inc, enhancing Osteopore’s leadership in the regenerative medicine sector and expanding its influence in the growing stem cell market.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean company specializing in regenerative medicine. It is recognized globally for its 3D-printed biomimetic and bioresorbable implants, focusing on innovations in tissue regeneration and longevity science.
Average Trading Volume: 3,098,075
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.85M
For an in-depth examination of OSX stock, go to TipRanks’ Overview page.